CPH — Cipher Pharmaceuticals Balance Sheet
0.000.00%
- CA$317.72m
- CA$349.22m
- $33.36m
- 80
- 44
- 39
- 55
Annual balance sheet for Cipher Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 9.14 | 20.5 | 28.8 | 39.8 | 17.8 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 9.22 | 6.66 | 6.8 | 5.09 | 13.9 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 20.1 | 29.3 | 38.2 | 48.3 | 38.5 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.91 | 0.501 | 0.481 | 0.402 | 0.68 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 44.3 | 51.7 | 73.8 | 86 | 163 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 9.92 | 12.3 | 9.37 | 5.25 | 19.9 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 11.6 | 12.8 | 9.7 | 5.51 | 60.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 32.6 | 38.9 | 64.1 | 80.5 | 102 |
Total Liabilities & Shareholders' Equity | 44.3 | 51.7 | 73.8 | 86 | 163 |
Total Common Shares Outstanding |